Frances Oldham Kelsey, the Fda, and the Battle Against Thalidomide - Warsh, Cheryl Krasnick (Professor of History, Professor of History,
37,99 €
inkl. MwSt.
Versandkostenfrei*
Sofort lieferbar
  • Gebundenes Buch

In the early 1960s, Dr. Frances Oldham Kelsey of the U.S. Food and Drug Administration became one of the most celebrated women in America when she prevented the deadly sedative thalidomide from entering the U.S. market. Her lifesaving work there became the basis for the FDA's current drug approval protocols. This biography brings to light the efforts and legacy of a pioneering woman in science whose contributions are still influential today.

Andere Kunden interessierten sich auch für
Produktbeschreibung
In the early 1960s, Dr. Frances Oldham Kelsey of the U.S. Food and Drug Administration became one of the most celebrated women in America when she prevented the deadly sedative thalidomide from entering the U.S. market. Her lifesaving work there became the basis for the FDA's current drug approval protocols. This biography brings to light the efforts and legacy of a pioneering woman in science whose contributions are still influential today.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Cheryl Krasnick Warsh is Professor of History at Vancouver Island University in Nanaimo, Canada. Dr. Warsh has published books on the history of asylums, women's health, children's health, consumerism, and alcohol and drug use. She served as long-term editor-in-chief of the Canadian Bulletin of Medical History and was co-editor of Gender & History. Dr. Warsh was a Fulbright Fellow, AMS/Hannah Fellow, and the inaugural recipient of the Vancouver Island University Distinguished Researcher Award. In 2017, she was elected a Fellow of the Royal Society of Canada for her contributions to Canadian medical history.